SCRI - Tennessee Oncology - Nashville - Centennial is a clinical research site located in Nashville, Tennessee, United States 58014.
Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.
SCRI - Tennessee Oncology - Nashville - Centennial has participated in 3 clinical trials with 1 currently active.
Therapeutic areas: Multiple Myeloma, Glioblastoma, Carcinoma, Non-Small-Cell Lung.
Sponsors: Takeda, Denovo Biopharma LLC.
Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
SCRI - Tennessee Oncology - Nashville - Centennial has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
SCRI - Tennessee Oncology - Nashville - Centennial has 3 clinical trials on record, with 1 currently active. Their work covers Multiple Myeloma, Glioblastoma, Carcinoma, Non-Small-Cell Lung.
SCRI - Tennessee Oncology - Nashville - Centennial has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.